Skip to content

Efficacy of Carboxymethyl Cellulose in Preventing Lymphatic Leakage After Axillary Lymph Node Dissection for Breast Cancer

Efficacy of Carboxymethyl Cellulose in Preventing Lymphatic Leakage After Axillary Lymph Node Dissection for Breast Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125030
Enrollment
Unknown
Registered
2026-05-20
Start date
2026-05-20
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphatic leakage after axillary lymph node dissection for breast cancer

Interventions

Experimental group:Carboxymethyl cellulose patches are adhered to the operation field after ALND.
Control group:conventional treatment

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged between 18 and 70 years (inclusive); 2. Pathologically confirmed invasive breast cancer; 3. Patients scheduled to undergo axillary lymph node dissection for breast cancer; 4. Subjects who voluntarily agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with known allergy to regenerated cellulose or its components (e.g., cellulose, oxidized groups, etc.); 2. Patients with other concurrent malignant tumors (e.g., lung cancer, gastric cancer, etc.) or distant metastasis of breast cancer; 3. Patients with coagulation disorders or active infections; 4. Patients with a history of prior axillary surgery; 5. Patients with severe dysfunction of vital organs (e.g., heart, lung, liver, kidney, brain) who cannot tolerate surgery or study intervention; 6. Patients with psychiatric disorders, cognitive impairment, or those unable to communicate effectively or comply with follow-up; 7. Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative lymphatic leakage;

Secondary

MeasureTime frame
Drainage fluid triglyceride and cholesterol concentration ;Extubation time;Duration of hospital stay ;Drainage volume daily;Incisional infection rate;

Countries

China

Contacts

Public ContactXu Xiaohong

The First Affiliated Hospital of Zhejiang Chinese Medical University

20163329@zcmu.edu.cn+86 571 8691 0509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026